Form 4 for TDOC Teladoc Health, Inc.

Accepted 2026-07-06 16:05:16 ET · period of report 2026-07-01 · accession 0001714468-26-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-07-06 16:05	2026-07-01	TDOC	Catapano Joseph Ronald	CAO	M - OptEx	—	+2,083	12.9K	+19%	—
D	2026-07-06 16:05	2026-07-02	TDOC	Catapano Joseph Ronald	CAO	S - Sale+OE	$9.10	-653	12.3K	-5%	-$5,942
D	2026-07-06 16:05	2026-07-01	TDOC	Catapano Joseph Ronald	CAO	M - OptEx	$0.00	-2,083	10.4K	-17%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-07-01	M	A	2,083	—	12,920	D	—	—	(F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis
2	Common	Common Stock	2026-07-02	S	D	653	$9.10	12,267	D	—	—	(F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
3	Derivative	Restricted Stock Units	2026-07-01	M	D	2,083	$0.00	10,418	D	— · — to —	2,083 Common Stock	(F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis (F3) On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. (F3) On October 1, 2024, the reporting person was granted 25,000 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.